Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva - Alexza Sign Deal for Adasuve
Yahoo/Zacks
Tuesday, May 14, 2013 - 8:29am
tags:
Teva, Adasuve, Alexza
Astellas forecasts big sales growth as prostate drug catches hold
Fierce Pharma
Monday, May 13, 2013 - 12:27pm
tags:
Astellas, Xtandi, Daiichi Sankyo, Japan, Takeda, prostate cancer
AbbVie, Pfizer's Zoetis deals ignite enormous leap in M&A value
Fierce Pharma
Monday, May 13, 2013 - 12:26pm
tags:
AbbVie, Pfizer, Zoetis, M&A, Abbott Laboratories
2 Medical Device Companies With Revolutionary Platforms
Seeking Alpha
Monday, May 13, 2013 - 12:23pm
tags:
devices, InVivo, Organovo, polymer scaffolding device, organ generation
Does Cell Therapy Hold The Key To Treating Stroke?
Seeking Alpha
Monday, May 13, 2013 - 11:34am
tags:
stroke, Cytomedix, Athersys, Pfizer, Baxter International
Did Elan Just Overpay On Theravance To Spurn Its Hostile Suitor?
Forbes
Monday, May 13, 2013 - 11:32am
tags:
Theravance, GSK, Elan, Royalty Pharma
Second Annual BioNJ Diagnostics & Personalized Medicine Innovation Summit Taking Place at Sanofi
CP Wire
Monday, May 13, 2013 - 11:30am
tags:
bionj, diagnostics, personalized medicine, Sanofi
SEC Is Investigating Spectrum Pharma
TheStreet.com
Monday, May 13, 2013 - 11:24am
tags:
SEC, Spectrum Pharmaceuticals, Fusilev
Novartis Scrambles To Woo Vets Angry Over Production Problems
Pharmalot
Monday, May 13, 2013 - 11:22am
tags:
Novartis, animal health
What Companies Will This FDA Decision Impact?
Wall St. Cheat Sheet
Monday, May 13, 2013 - 11:20am
tags:
FDA, generics, Opana ER, Endo Health Solutions, Actavis, Impax Laboratories
Elan enters $1 billion royalty deal with Theravance over potential respiratory drug sales
Yahoo/AP
Monday, May 13, 2013 - 9:36am
tags:
Elan, Theravance, GSK, Anoro Ellipta, Breo Ellipta
Warner Chilcott shares rise in premarket on optimism about potential combination with Actavis
Yahoo/AP
Monday, May 13, 2013 - 9:22am
tags:
Actavis, M&A, Warner Chilcott
Is Johnson & Johnson Heading Off The Patent Cliff?
Seeking Alpha
Monday, May 13, 2013 - 9:12am
tags:
JNJ, patent cliff, Novartis, Pfizer, Aciphex, Procrit, Velcade, Remicade
Human Immune-Boosting Cancer Drugs Seen Extending Lives
Bloomberg
Monday, May 13, 2013 - 9:11am
tags:
cancer, Merck, Bristol-Myers Squibb, Roche
A Closer Look at GlaxoSmithKline's Dividend Potential
Motley Fool
Monday, May 13, 2013 - 9:08am
tags:
dividends, GSK
Sequenom Meets on the Top Line, Misses Where it Counts
Motley Fool
Sunday, May 12, 2013 - 11:14am
tags:
Sequenom
6 Big Pharma Stocks With Lower Credit Risk Than U.S. Treasuries: Part II
Motley Fool
Sunday, May 12, 2013 - 11:10am
tags:
Merck, Novartis, Pfizer
China Biotech In Review: Sagent Buys Out China JV Partner For $25 Million
Seeking Alpha
Sunday, May 12, 2013 - 11:09am
tags:
ScinoPharm, Sagent Pharmaceuticals, Huahai Pharma, Oncobiologics, Chi-Med, Beta Pharma, Amgen, Beijing Leadman Biochemistry
London-Based Hedgie Focusing On Big Pharma
Motley Fool
Sunday, May 12, 2013 - 11:04am
tags:
Pfizer, Merck, Eli Lilly
Pernix Therapeutics Reports First Quarter 2013 Financial Results
Enhanced Online News
Sunday, May 12, 2013 - 11:03am
tags:
Pernix, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.